HEALTH
Industry executives and investment bankers said some of the biggest global drugmakers are scouring for deals in China to replenish drug pipelines and boost their presence in the world's second-biggest pharmaceutical market. Several major deals have already been completed this year, including AstraZeneca's $1.2 billion purchase of China-based cell therapy
US Bill Combats Fentanyl and Other Deadly Opioids
President Donald Trump has signed into law a bill combating the nation’s opioid epidemic, which he last...